
AksharChem India: Munjal Jaykrishna Re-appointed MD & CEO
AksharChem India Ltd announced key management changes following its Board of Directors meeting on October 19, 2026. Mr. Munjal M. Jaykrishna has been re-appointed as Managing Director & CEO for a three-year term effective October 19, 2026, subject to shareholder approval. Additionally, Mr. Sachin M. Jaykrishna's remuneration as Whole Time Director has been revised effective October 19, 2026, and his re-appointment for another three-year term commencing August 02, 2027, has also been approved, pending shareholder and other necessary approvals. The company also approved its unaudited financial results for the quarter and half-year ended September 30, 2026.
Key Highlights
- Munjal M. Jaykrishna re-appointed MD & CEO for three years.
- Sachin M. Jaykrishna's remuneration revised and re-appointment approved.
- Unaudited financial results for Q2 FY27 approved.
- Key appointments subject to shareholder approval.
Price Impact
More from AKSHARCHEM
AksharChem India Board Approves Unaudited Results, MD & CEO Re-appointment
AksharChem swings to ₹13.3 Cr standalone profit in Q2 FY27 as revenue surges 80% YoY
Aksharchem India Board Meeting on Oct 19 to Approve Unaudited Results